Opioid Reduction Strategy South Western Ontario

NANot yet recruitingINTERVENTIONAL
Enrollment

100,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

March 1, 2025

Conditions
Opioid Use
Interventions
OTHER

Opioid Reduction Strategy

The intervention will involve a multi-faceted 3 component approach involving 1) opioid prescription caps (default maximum number of tablets for discharge prescriptions, as defined by evidence-based guidelines) 2) patient education tools (e.g. What is a normal pain trajectory? How to manage the pain? Benefits and potential harms of pharmacologic analgesia. Non-pharmacologic analgesia management? What to do if pain is excessive?), 3) provider education tools (e.g. including procedure-specific evidence-based recommendations for multi-modal analgesia; comparison of local baseline prescribing patterns with exemplary prescribing patterns; defining targeted reduction if baseline prescribing is at odds with best evidence; review of best evidence about optimal analgesia perioperatively), and 4) bi-weekly cumulative prescriber feedback on opioid prescribing patterns post-intervention and until end-of-study.

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT04944225 - Opioid Reduction Strategy South Western Ontario | Biotech Hunter | Biotech Hunter